A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03834753 |
|
Recruitment Status :
Completed
First Posted : February 8, 2019
Last Update Posted : February 17, 2022
|
Sponsor:
Outlook Therapeutics, Inc.
Information provided by (Responsible Party):
Outlook Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 7, 2021 |
| Actual Study Completion Date : | July 8, 2021 |
| Certification/Extension First Submitted : | November 16, 2021 |